Compare DERM & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | SPOK |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 228.7M |
| IPO Year | 2021 | 2004 |
| Metric | DERM | SPOK |
|---|---|---|
| Price | $7.11 | $10.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $12.67 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 338.9K | 176.3K |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.31% |
| EPS Growth | ★ 34.72 | 2.74 |
| EPS | N/A | ★ 0.09 |
| Revenue | $61,858,000.00 | ★ $139,708,000.00 |
| Revenue This Year | $39.72 | $1.70 |
| Revenue Next Year | $63.24 | N/A |
| P/E Ratio | ★ N/A | $117.44 |
| Revenue Growth | ★ 10.20 | 1.49 |
| 52 Week Low | $4.31 | $9.95 |
| 52 Week High | $9.56 | $19.31 |
| Indicator | DERM | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 47.31 |
| Support Level | $7.00 | $10.41 |
| Resistance Level | $7.69 | $11.07 |
| Average True Range (ATR) | 0.44 | 0.31 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 86.21 | 40.26 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.